How long is enough? Evidence gaps and research priorities for antibiotic duration in immunocompromised hosts

M Mazzitelli; Riccardo Serraino; Enrico Maria Trecarichi; Rita Murri; Carlo Torti

doi:10.1080/14787210.2026.2692475

June 18, 2026Expert Review of Anti-infective Therapy

How long is enough? Evidence gaps and research priorities for antibiotic duration in immunocompromised hosts

View at Publisher

Ask AI

Bookmark

Share

Key Points

To identify evidence gaps and establish research priorities for antibiotic duration in immunocompromised hosts.
Review of existing literature on antibiotic duration in immunocompromised populations.
Analysis of current practices and recommendations concerning antimicrobial resistance (AMR).
Identification of key areas lacking evidence in antibiotic duration for immunocompromised individuals.
Recommendations for strengthening diagnostic stewardship programs to combat AMR.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Explores evidence gaps in antibiotic duration for immunocompromised hosts, highlighting key research priorities.

Abstract

In the literature an interesting discussion is emerging on antimicrobial resistance (AMR) in immunocompromised people and the parallel call to strengthen diagnostic stewardship programs in this ...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Mazzitelli et al. (2026) studied this question.

synapsesocial.com/papers/6a3632fcdb0793dc1a53976b https://doi.org/10.1080/14787210.2026.2692475

View at Publisher

Ask AI

Bookmark

Share

How long is enough? Evidence gaps and research priorities for antibiotic duration in immunocompromised hosts

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

How long is enough? Evidence gaps and research priorities for antibiotic duration in immunocompromised hosts

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading